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Abstract. 
 
Budding yeast initiates anaphase by activat-
ing the Cdc20-dependent anaphase-promoting complex 
(APC). The mitotic activity of Cdc28 (Cdk1) is required 
to activate this form of the APC, and mutants that are 
impaired in mitotic Cdc28 function have difﬁculty leav-
ing mitosis. This defect can be explained by a defect in 
APC phosphorylation, which depends on mitotic Cdc28 
activity in vivo and can be catalyzed by puriﬁed Cdc28 
in vitro. Mutating putative Cdc28 phosphorylation sites 
in three components of the APC, Cdc16, Cdc23, and 
Cdc27, makes the APC resistant to phosphorylation 
both in vivo and in vitro. The nonphosphorylatable 
APC has normal activity in G1, but its mitotic, Cdc20-
dependent activity is compromised. These results show 
that Cdc28 activates the APC in budding yeast to trig-
ger anaphase. Previous reports have shown that the 
 
budding yeast Cdc5 homologue, Plk, can also phosphor-
ylate and activate the APC in vitro. We show that, like 
 
cdc28 
 
mutants, 
 
cdc5
 
 mutants affect APC phosphoryla-
tion in vivo. However, although Cdc5 can phosphory-
late Cdc16 and Cdc27 in vitro, this in vitro phosphoryla-
tion does not occur on in vivo sites of phosphorylation.
Key words: mitosis • budding yeast • Cdc5 • Cks1 • 
Pds1
 
Introduction
 
Proteolysis plays a critical role in the eukaryotic cell cycle.
During the exit from mitosis, ubiquitin mediated proteoly-
sis destroys an inhibitor of sister chromatid separation
(Pds1 in budding yeast and Cut2 in fission yeast; Holloway
et al., 1993; Funabiki et al., 1996; Yamamoto et al., 1996)
and the mitotic cyclins (Clb1–Clb4 in budding yeast; Ghi-
ara et al., 1991; Glotzer et al., 1991; Yamano et al., 1996).
These proteins are targeted for degradation by the ana-
phase-promoting complex (APC)
 
1
 
 or cyclosome, which is
the E3 ubiquitin ligase for cyclins (King et al., 1995;
Sudakin et al., 1995; Zachariae et al., 1996), Pds1 (Cohen-
Fix et al., 1996; Funabiki et al., 1997), and other substrates
(Juang et al., 1997; Prinz et al., 1998; Shirayama et al.,
1998), marking them for destruction by the 26S protea-
some. The APC is regulated by the binding of two con-
served activators, Cdc20 and Hct1 (also known as Cdh1;
Schwab et al., 1997; Visintin et al., 1997; Fang et al., 1998b;
Kitamura et al., 1998; Lorca et al., 1998). In budding yeast,
Cdc20-dependent APC activity initiates the metaphase to
anaphase transition and the series of events that activate
the Hct1-dependent APC, which induces complete mitotic
cyclin destruction (Lim and Surana, 1996; Visintin et al.,
1997; Shirayama et al., 1999). Hct1 acts in conjunction with
the cyclin-dependent kinase (Cdk) inhibitor Sic1 to induce
the rapid drop in Cdc28-associated kinase activity that
drives cells out of mitosis and into the next G1 (Menden-
hall, 1993; Donovan et al., 1994; Amon, 1997; Li and Cai,
1997). The Hct1- and the Cdc20-dependent APC can both
target Pds1 for destruction (Visintin et al., 1997; Rudner et
al., 2000), suggesting that the main difference between
them is the time during the cell cycle when each is active
(Prinz et al., 1998).
Phosphorylation of Hct1 by Cdc28/Clb complexes keeps
it from binding or activating the APC (Zachariae et al.,
1998; Jaspersen et al., 1999). This phosphorylation is
removed by Cdc14, a phosphatase that is activated af-
ter Cdc20-dependent destruction of Pds1, Clb2, and the
S-phase cyclin, Clb5 (Visintin et al., 1998; Jaspersen et al.,
1999; Shirayama et al., 1999; Yeong et al., 2000). The late
activation of Cdc14 ensures that cells do not inactivate
Cdc28 and exit mitosis until well after they have initiated
sister chromatid segregation.
Cdc20 is regulated in at least three ways: the gene is
transcribed only in mitosis, the protein is targeted for de-
struction by the APC, and Cdc20 activity is inhibited by
the spindle checkpoint, which monitors whether chromo-
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somes have attached to the spindle properly (Weinstein,
1997; Fang et al., 1998a; Hwang et al., 1998; Kallio et al.,
1998; Kim et al., 1998; Kramer et al., 1998; Prinz et al., 1998;
Shirayama et al., 1998).
The Cdc20-dependent APC is regulated by phosphory-
lation. APC subunits are phosphorylated in fission yeast,
frogs, clams, and mammalian tissue culture cells (Hershko
et al., 1994; Peters et al., 1996; Yamada et al., 1997; Kotani
et al., 1998). Phosphorylation correlates with APC activity
in vivo, and experiments in vitro have suggested that phos-
phorylating the APC regulates Cdc20 binding and APC
activity (Kotani et al., 1998, 1999; Shteinberg et al., 1999).
Studies in frog egg extracts and mammalian tissue culture
cells have shown that the protein kinase Plk (known as
Cdc5 in budding yeast and Plx1 in frogs) and the complex
of Cdc2, Cyclin B, and Cks1, a small Cdk binding protein,
can phosphorylate the APC in vitro. Depletion of either
Cks1 or Plx1 from frog extracts blocks cyclin destruction,
suggesting that both Cdc2 and Plx1 may activate the APC
(Patra and Dunphy, 1996; Descombes and Nigg, 1998; Ko-
tani et al., 1998, 1999), but the relative importance of these
two kinases in vivo is unclear. Phosphorylation of the APC
by cAMP-dependent protein kinase A inhibits the APC
both in vivo and in vitro (Yamashita et al., 1996; Kotani et
al., 1998). Lastly, protein phosphatase 2A (PP2A) inhibits
the APC (Lahav-Baratz et al., 1995; Shteinberg et al.,
1999), whereas PP1 activates the APC (Yamada et al.,
1997).
In the accompanying paper (Rudner et al., 2000), we
show that 
 
CDC28-T18V
 
,
 
 Y19F 
 
(
 
CDC28-VF)
 
,
 
 
 
and other
mutants with altered mitotic Cdc28 activity are compro-
mised in activating the Cdc20-dependent APC, revealing a
requirement for Cdc28 in APC activation. Here, we show
that 
 
CDC28-VF
 
 is defective in the mitotic phosphorylation
of the APC and that this phosphorylation depends on
Cdc28 activity both in vivo and in vitro. Mutating potential
phosphorylation sites in the APC components Cdc16,
Cdc23, and Cdc27 reduces Cdc20 binding to the APC and
Cdc20-dependent APC activity in vivo.
 
Materials and Methods
 
Strain and Plasmid Construction
 
Table I lists the strains used in this work. All strains are derivatives of the
W303 strain background (W303-1a; Rodney Rothstein, Columbia Univer-
sity, NY). Standard genetic techniques were used to manipulate yeast
strains (Sherman et al., 1974) and standard protocols were used for DNA
manipulation (Maniatis et al., 1982). All deletions and replacements were
confirmed by PCR or by mutant phenotype. The sequences of all primers
used in this study are available upon request. The bacterial strains TG1
and DH5
 
a
 
 were used for amplification of DNA.
 
BAR1
 
 was deleted using pJGsst1 (a gift of Jeremy Thorner, University
of California, Berkeley, CA). 
 
CDC27-MBP 
 
strains were made by crossing
JC35 (a gift of Julia Charles, University of California, San Francisco, CA)
to the appropriate strains. 
 
cdc26
 
D
 
 strains were described previously
(Hwang and Murray, 1997).
 
 clb2
 
D
 
 strains were made by crossing K1890 (a
gift of Kim Nasmyth, Institute of Molecular Pathology, Vienna, Austria)
to the appropriate strains. 
 
pCUP-GFP12-lacI12 
 
and 
 
lacO:LEU2 
 
were in-
tegrated using pSB116 (Biggins et al., 1999) and pAFS59 (Straight et al.,
1996), respectively. 
 
pGAL-MPS1 
 
strains were made with pAFS120
(Hardwick et al., 1996). 
 
pGAL-PDS1-HA 
 
strains were made by crossing
RTK43 (a gift of Rachel Tinker-Kulberg, Johns Hopkins University, MD)
to the appropriate strains. 
 
APC9 
 
was tagged by the PCR-targeting
method. Cells were transformed with a cassette containing the bacterial
 
KAN
 
R 
 
gene that confers G418 resistance in W303. The cassette was ampli-
fied by PCR from pFA6a-3HA-kanMX6 (Longtine et al., 1998) with
 
 
 
prim-
ers containing the sequences that flank the stop codon of 
 
APC9
 
. The con-
struction of 
 
CDC20-myc12 
 
and 
 
cks1-38 
 
is described in Rudner et al. (2000,
this issue).
Alanine-substituted mutants in 
 
CDC16
 
, 
 
CDC23
 
, and 
 
CDC27 
 
were
made using site-directed mutagenesis (Kunkel, 1985). Mutations were
confirmed by the introduction of new restriction enzyme sites and by se-
quencing (ABI). For 
 
CDC16
 
, the EcoR1/Xho1 fragment of pWAM10
(Lamb et al., 1994) was cloned into KS (
 
2
 
) (Stratagene) to create pAR290.
pAR290 was mutagenized to create pAR293, which contains all six serine/
threonine to alanine substitutions. pAR294 was cut with EcoRI and NotI,
and ligated to a EcoRI/PstI PCR fragment that contains the 3
 
9
 
 end of
 
CDC16
 
, a PstI/SpeI PCR fragment that contains the 
 
TRP1 
 
gene, and a
SpeI/NotI PCR fragment that contains the 3
 
9
 
 untranslated region of the
 
CDC16 
 
gene. The resultant plasmid, pAR303, was cut with XhoI and
NotI, and integrated at the 
 
CDC16 
 
locus. The 
 
TRP
 
1
 
 
 
transformants were
screened by PCR for the presence of all mutations. For 
 
CDC23
 
, the
BamHI/NotI fragment of pRS239 (Lamb et al., 1994) was cloned into KS
(
 
2
 
) to create pAR228. pAR228 was mutagenized to create pAR240,
which contains the single serine to alanine substitution in 
 
CDC23
 
.
pAR228 was cut with BamHI and NotI, transformed into 
 
cdc23-1 
 
cells
(ADR1285), and selected for growth at 37
 
8
 
C. Transformants were
screened by Western blot for the HA tag present at the 3
 
9
 
 end of the gene,
and by PCR for the presence of the alanine substitution. For 
 
CDC27
 
, the
PstI/NotI fragment of pJL25 (Lamb et al., 1994) was cloned into KS (
 
2
 
) to
create pAR201. pAR201 was mutagenized to create pAR203, which con-
tains all five serine/threonine to alanine substitutions in 
 
CDC27
 
. pAR203
was cut with NdeI and NotI, and ligated to a NdeI/XbaI PCR fragment
that contains the 
 
KAN
 
R
 
 
 
gene and a XbaI/NotI PCR fragment containing
the 3
 
9
 
 untranslated region of 
 
CDC27
 
. The resultant plasmid, pAR271, was
cut with KpnI and NotI, and integrated at the 
 
CDC27
 
 locus. Transfor-
mants were screened by PCR for the presence of all mutations.
 
Physiology
 
Physiological experiments were performed as described in the accompa-
nying paper (Rudner et al., 2000, this issue). Hydroxyurea (HU; Sigma-
Aldrich) was added directly to media at a final concentration of 200 mM.
Cells were fixed for indirect immunofluorescence in 3.7% formalde-
hyde for 1 h. The spindles were visualized by antialpha-tubulin (Harlan
Sera-Lab) immunofluorescence as described previously (Hardwick and
Murray, 1995), except that the blocking reagent used was 2% BSA, PBS.
Short spindles are bipolar spindles 
 
,
 
2 
 
m
 
m long.
 
Immunoprecipitation and Western Blots
 
Immunoprecipitation, Western blots, APC assay, and Cdc20 binding to
the APC were performed as described in the accompanying paper (Rud-
ner et al., 2000). Modifications of the basic protocol are detailed below.
To resolve the phosphorylated forms of Cdc27 by Western blot, sam-
ples were electrophoresed on a 12.5% polyacrylamide gel containing
0.025% bisacrylamide. The phosphorylated forms of Cdc16 were resolved
by Western blot on a 10% polyacrylamide gel containing 0.13% bisacryl-
amide.
The following antibodies were used in this study: 9E10 ascites
(BabCO); affinity-purified rabbit polyclonal anti-Clb2 and anti-Clb3 anti-
bodies (Kellogg and Murray, 1995); rabbit polyclonal anti-Sic1 serum (a
gift of Mike Mendenhall, University of Kentucky, Lexington, KY); 12CA5
ascites (BabCO); rabbit polyclonal anti-Cdc16, anti-Cdc23, and anti-
Cdc27 (Lamb et al., 1994); and rabbit polyclonal anti-Cdc26 antibody
(Hwang and Murray, 1997). Details on the use of these antibodies can be
found in the accompanying paper (Rudner et al., 2000).
 
In Vivo Labeling of the APC
 
Yeast cells were arrested in G1 with alpha factor, in S-phase with HU, and
in mitosis by spindle checkpoint activation and temperature shift. Once
the cells were arrested at the indicated stage of the cell cycle, 50 ml of
OD
 
600
 
 0.8 cells were harvested by centrifugation, washed twice in H
 
2
 
O,
and resuspended in 1 ml phosphate-free complete synthetic medium (Roth-
blatt and Schekman, 1989) containing 0.5–1 mCi 
 
32
 
PO
 
4
 
 (Amersham Phar-
macia Biotech). Cells were labeled for 1 h, harvested by centrifugation,
washed once in H
 
2
 
O, and were then frozen in screw-cap tubes (Sarstedt).
These tubes were used throughout the procedure to prevent radioactive
contamination. The frozen yeast pellets were processed for immunopre-
cipitation as described in the accompanying paper (Rudner et al., 2000) 
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with the following modifications. 2–3 
 
m
 
g anti-Cdc26 antibody was bound
to 20 
 
m
 
l protein A beads for 20 min on ice. These beads were then incu-
bated with 10–20 mg of unlabeled cell lysate made from 
 
cdc26
 
D
 
 cells for
1–2 h. After incubation, the beads were washed twice in lysis buffer. At
the same time, the labeled cell lysate (typically 10 mg) was precleared in
75 
 
m
 
l protein A CL-4B Sepharose beads (Sigma-Aldrich) for 1 h, and then
centrifuged at 14,000 rpm for 5 min at 4
 
8
 
C. The labeled lysate was then
added to the antibody-bound protein A beads and incubated with rotation
for 1–2 h. The beads were washed four times with kinase bead buffer (500
mM NaCl, 50 mM Tris-Cl, pH 7.4, 50 mM NaF, 5 mM EGTA, 5 mM
EDTA, 0.1% Triton X-100; transferring the beads to fresh tubes after the
fourth wash), and then twice with 50 mM Tris-Cl, pH 7.5. The beads were
then rotated in 50 mM Tris-Cl, pH 7.5, containing 0.5 mg/ml RNAse A for
30 min at 4
 
8
 
C, washed an additional two times in kinase bead buffer
(transferring the beads to fresh tubes after the second wash), and then a fi-
nal wash in 50 mM Tris-Cl, pH 7.5.
 
In Vitro Phosphorylation of the APC
 
Cells were arrested in G1 by alpha factor, were harvested by centrifuga-
tion, frozen, and processed for immunoprecipitation. 10–15 mg of cell ly-
sate was precleared in 50 
 
m
 
l protein A beads, and then the APC was im-
munoprecipitated with 2 
 
m
 
g anti-Cdc26 antibodies that were prebound to
 
protein A beads as described above. After immunoprecipitation, the
beads were washed three times in kinase bead buffer (transferring the
beads to fresh tubes after the second wash), and then twice in low salt
kinase buffer (10 mM NaCl, 20 mM Hepes-KOH, pH 7.4, 5 mM MgCl
 
2
 
,
1 mM DTT). 5 ng of purified Cdc28-His
 
6
 
, 50 ng purified Clb2-MBP (gifts
of Jeff Ubersax, University of California, San Francisco, CA), and 100 ng
purified Cks1 (see below) in 2 
 
m
 
l of kinase dilution buffer (300 mM NaCl,
25 mM Hepes-KOH, pH 7.4, 10% glycerol, 0.1 mg/ml BSA) were added
to a 13 
 
m
 
l of low salt kinase buffer containing 10 
 
m
 
m ATP, 2 
 
m
 
Ci
 
g
 
[
 
32
 
P]ATP (Amersham Pharmacia Biotech), and 10 
 
m
 
m okadaic acid
(Calbiochem-Novabiochem). This reaction mix was added to the immu-
noprecipitated APC and incubated at 25
 
8
 
C for 20 min. The beads were
then washed three times in kinase bead buffer containing 1 
 
m
 
m okadaic
acid (transferring the beads to fresh tubes after the second wash), and
then twice in low salt kinase buffer containing 1 
 
m
 
m okadaic acid. These
washes remove Clb2-MBP and proteolytic fragments of Clb2-MBP,
which are well phosphorylated and obscure APC phosphorylation. Cdc5
phosphorylation was performed by adding the following to immunopre-
cipitated APC: purified His
 
6
 
-HA-Cdc5 (a gift of Julia Charles, University
of California, San Francisco, CA) in 5 
 
m
 
l of Cdc5 storage buffer (250 mM
KCl, 20 mM Hepes-KOH, pH 7.4, 10% glycerol, 5 mM NaF, 0.1 mg/ml
BSA) added to 15 
 
m
 
l of Cdc5 kinase reaction buffer (20 mM KCl, 20 mM
Hepes-KOH, pH 7.4, 2 mM MgCl
 
2
 
, 2 mM MnCl
 
2
 
; final concentrations in
 
Table I. Strain List
 
Name
 
MAT
 
Relevant genotype* Source
 
ADR313
 
a
 
clb2
 
D
 
::LEU2 
 
This study
ADR376
 
a
 
bar1
 
D
 
This study
ADR477
 
a
 
CDC28-HA:URA3
 
This study
ADR483
 
a
 
cdc28-1N 
 
This study
ADR509
 
a
 
CDC28-VF-HA:URA3
 
This study
ADR842
 
a
 
cdc28-4 
 
This study
ADR1252
 
a
 
CDC28-VF-HA:URA3 bar1
 
D
 
This study
ADR1389
 
a
 
CDC28-HA:URA3 bar1
 
D
 
This study
ADR1606
 
a
 
clb2
 
D
 
:LEU2 ura3-1:pGAL-MPS1:URA3
 
This study
ADR1705
 
a
 
CDC27-MBP bar1
 
D
 
This study
ADR1767
 
a
 
cks1
 
D
 
::KAN
 
R
 
 trp1-1:cks1-38:TRP1
 
This study
ADR1790
 
a
 
cdc15-2 CDC20-myc12 CDC28-HA:URA3 
 
This study
ADR1899
 
a
 
cdc28-1N ura3-1:pGAL-MPS1:URA3
 
This study
ADR1968
 
a
 
CDC28-HA:URA3 trp1-1:pGAL-PDS1-HA:TRP1 bar1
 
D
 
This study
ADR1973
 
a
 
CDC23-A-HA ura3-1:pGAL-MPS1:URA3 
 
This study
ADR1974
 
a
 
CDC27-5A:KAN
 
R 
 
ura3-1:pGAL-MPS1:URA3 
 
This study
ADR1975
 
a
 
CDC16-6A:TRP1 ura3-1:pGAL-MPS1:URA3 
 
This study
ADR1976
 
a
 
CDC23-A-HA CDC27-5A:KAN
 
R
 
 ura3-1:pGAL-MPS1:URA3 
 
This study
ADR1977
 
a
 
CDC16-6A:TRP1 CDC23-A-HA ura3-1:pGAL-MPS1:URA3 
 
This study
ADR1978
 
a
 
CDC16-6A:TRP1 CDC27-5A:KAN
 
R 
 
ura3-1:pGAL-MPS1:URA3 
 
This study
ADR1979
 
a
 
CDC16-6A:TRP1 CDC23-A-HA CDC27-5A:KAN
 
R 
 
ura3-1:pGAL-MPS1:URA3 
 
This study
ADR1987
 
a
 
cdc15-2 CDC27-5A:KAN
 
R 
 
CDC20-myc12 CDC28-HA:URA3 
 
This study
ADR1990
 
a
 
cdc15-2 CDC16-6A:TRP1 CDC20-myc12 CDC28-HA:URA3 
 
This study
ADR1999
 
a
 
CDC27-5A:KANR trp1-1:pGAL-PDS1-HA:TRP1 This study
ADR2003 a CDC16-6A:TRP1 trp1-1:pGAL-PDS1-HA:TRP1 This study
ADR2023 a cdc26D::HIS3 ura3-1:pGAL-MPS1:URA3  This study
ADR2029 a CDC16-6A:TRP1 bar1D This study
ADR2030 a CDC23-A-HA bar1D This study
ADR2031 a CDC27-5A:KANR bar1D This study
ADR2032 a CDC16-6A:TRP1 CDC23-A-HA CDC27-5A:KANR bar1D This study
ADR2036 a cdc26D::LEU2 CDC20-myc12  This study
ADR2042 a APC9-HA3:KANR bar1D This study
ADR2061 a his3-11,15:pCUP1-GFP-lacI:HIS3 leu2-3,112:lacO:LEU2 bar1D  This study
ADR2064 a CDC16-6A:TRP1 CDC23-A-HA CDC27-5A:KANR his3-11,15:pCUP1-GFP-lacI:HIS3 leu2-3,112:lacO:LEU2 bar1D This study
JC145 a cdc5-1 bar1D Julia Charles
JC165 a cdc5-1 ura3-1:pGAL-MPS1:URA3  Julia Charles
K6180 a CDC16-myc6:URA3 balD Kim Nasmyth
KH153‡ a ura3-1:pGAL-MPS1:URA3 Kevin Hardwick
KH181 a CDC28-VF-HA:URA3 ura3-1:pGAL-MPS1:URA3  Kevin Hardwick
LH307 a cdc26D::LEU2 bar1D Lena Hwang
SLJ378 a CDC23-HA bar1D Sue Jaspersen
*All strains are isogenic to W303-1a (MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1).
‡All pGAL-MPS1 strains are derived from crosses with KH153.The Journal of Cell Biology, Volume 149, 2000 1380
20 ml reaction) containing 10 mm ATP, 2 mCi g[32P]ATP, and 10 mm oka-
daic acid.
Cks1 Bead Pulldowns
Cks1 protein was made as described previously (Booher et al., 1993) us-
ing pCKS1-1. After the ammonium sulfate precipitation, the pellet was
resuspended in lysis buffer (50 mM Tris-Cl, pH 8.0, 2 mM EDTA, 10%
glycerol) and then desalted on a PD-10 column (Amersham Pharmacia
Biotech) that had been equilibrated in CnBr coupling buffer (500 mM
NaCl, 100 mM Na2CO3, pH 8.3). Cks1 was then coupled to CnBr-acti-
vated Sepharose 6MB or 4B (Amersham Pharmacia Biotech) according
to the manufacturer’s instructions. Beads were washed and stored in lysis
buffer (100 mM NaCl, 50 mM Tris-Cl, pH 7.5, 50 mM NaF, 50 mM Na-
b-glycerophosphate, pH 7.4, 2 mM EGTA, 2 mM EDTA, 0.1% Triton
X-100, 0.02% NaN3). 3–5 mg of cell lysate was incubated with 10 ml Cks1-
coupled beads for 1–2 h, washed three times in kinase bead buffer (500
mM NaCl, 50 mM Tris-Cl, pH 7.4, 50 mM NaF, 5 mM EGTA, 5 mM
EDTA, 0.1% Triton X-100; transferring the beads to fresh tubes after the
second wash), and then twice in low salt kinase buffer. Phosphatase treat-
ment of Cks1 bead pulldowns was performed as previously described
(Hardwick and Murray, 1995) using lambda phosphatase (New England
Biolabs, Inc.).
Results
Cdc28 Phosphorylates the APC In Vitro
Mutants that reduce mitotic Cdc28 activity have difficulty
activating the Cdc20-dependent APC, suggesting that
Cdc28 might phosphorylate the APC or Cdc20 (Rudner et
al., 2000). Therefore, we asked if the budding yeast APC is
phosphorylated in vitro. We used APC that was isolated
by immunoprecipitating cell lysates with antibodies against
Cdc26, a nonessential component of the APC (Hwang and
Murray, 1997), and used these immunoprecipitates as a
substrate for purified recombinant Cdc28/Clb2/Cks1 (a
gift of Jeff Ubersax and David Morgan, University of Cali-
fornia, San Francisco, CA) in the presence of g[32P]ATP.
In APC isolated from wild-type cells, three major bands
and a single minor band were phosphorylated (Fig. 1, top).
We determined the identity of these four bands by
phosphorylating the APC isolated from cells containing
epitope-tagged subunits that change their molecular weight.
If the band shifted up in the epitope-tagged APC, we con-
cluded that the phosphorylated protein is the APC sub-
unit. By this criterion, the protein at 97 kD is Cdc16, the
protein at 85 kD is Cdc27, and the minor species at 65 kD
is Cdc23 (Fig. 1, top). Similar experiments have shown the
band at 42 kD is Apc9 (data not shown).
We do not think the phosphorylation of the APC in
these reactions is due to kinases that coimmunoprecipitate
with the APC; no labeling is seen in immunoprecipitates
lacking added Cdc28/Clb2/Cks1. However, a kinase bound
to the APC might need to be activated by Cdc28, as has
been reported for Plk phosphorylation of the mammalian
APC (Kotani et al., 1998). Therefore, we tested whether
Cdc5, the Plk homologue in budding yeast, was required
for in vitro APC phosphorylation (Kitada et al., 1993). We
isolated the APC from a cdc5-1 mutant that had been ar-
rested in G1 by alpha factor at 258C and then shifted to the
restrictive temperature of 378C for one hour. This APC is
fully phosphorylated in vitro by Cdc28 (Fig. 1), showing
that Cdc5 is not required for APC phosphorylation in this
in vitro assay. In addition, Cdc5 is not detectable in alpha
factor-arrested cells (Hardy and Pautz, 1996; Charles et
al., 1998; Shirayama et al., 1998), or in anti-Cdc26 immu-
noprecipitates of the APC, isolated from mitotic cells that
contain Cdc5 (David Morgan, personal communication;
and data not shown).
The APC Is Phosphorylated In Vivo
Is the APC phosphorylated in vivo? Wild-type cells were
arrested at three points in the cell cycle: during G1 by add-
ing alpha factor (a mating pheromone), during S-phase by
adding HU (a DNA synthesis inhibitor), and in mitosis
with nocodazole (a microtubule polymerization inhibitor).
The arrested cells were labeled with 32PO4 and the APC
was isolated by immunoprecipitating cell lysates with anti-
bodies against Cdc26. Three major proteins of 97, 85, and
65 kD were strongly labeled in nocodazole-arrested cells,
and to a lesser extent in HU- and alpha factor-arrested
cells (Fig. 2 A). These three proteins do not precipitate
from cdc26D cells. The molecular weights of these proteins
suggest that they are the APC subunits Cdc16, Cdc27, and
Cdc23, and mutating phosphorylation sites in these pro-
Figure 1. The APC is phosphorylated in vitro by Cdc28. Wild-
type (ADR376), CDC27-MBP (ADR1705), CDC16-myc6
(K6180),  CDC23-HA  (SLJ378), and cdc5-1 (JC145) were grown
overnight in YEP 1 2% glucose at 238C to log phase, arrested in
G1 by alpha factor (1 mg/ml) for 3 h, harvested, lysed, and the
APC immunoprecipitated with anti-Cdc26 antibody. The immu-
noprecipitates were treated with purified Cdc28-His6, Clb2-MBP,
Cks1, and g[32P]ATP, were washed to remove phosphorylated
Clb2-MBP, and were then run on a polyacrylamide gel that was
subjected to autoradiography (top) or Western blotting (bot-
tom).  cdc5-1 cells were shifted to 378C for an additional 1 h of al-
pha factor treatment. As controls, cell lysate was mock precipi-
tated in the absence of anti-Cdc26 antibody (no anti-Cdc26) or
was precipitated in the presence of anti-Cdc26 antibody, but no
Cdc28, Clb2, or Cks1 was added to kinase reaction (no kinase).
The Western blot shows that similar amounts of APC were pre-
cipitated with the anti-Cdc26 antibody.Rudner and Murray Cdc28 Phosphorylates the APC 1381
Figure 2. The APC is phosphorylated in vivo. A, APC phosphorylation is greatest in mitosis. Wild-type (ADR376) and cdc26D
(LH307) were grown overnight in YEP 1 2% glucose at 238C to log phase and then arrested in G1 with alpha factor (1 mg/ml), in
S-phase with hydroxyurea (200 mM), or in mitosis with nocodazole (10 mg/ml) for 3 h. Cells were then transferred to phosphate-free
CSM 1 2% glucose containing 32PO4, and alpha factor, HU, or nocodazole as indicated. After 1 h cells were harvested, lysed, and the
APC was immunoprecipitated with anti-Cdc26 antibody. Immunoprecipitates were run on a polyacrylamide gel that was subjected to
either autoradiography (top) or Western blotting (bottom). B and C, CDC28-VF, clb2D, cdc28-1N, and cdc5-1 have reduced APC phos-
phorylation in vivo. All strains contain pGAL-MPS1. Wild-type  (KH153),  CDC28-VF  (KH181),  clb2D (ADR1606), cdc28-1N
(ADR1899),  cdc5-1  (JC165), and cdc26D (ADR2023) were grown overnight in YEP 1 2% raffinose at 238C to log phase, and were then
transferred to YEP 1 2% galactose for 4 h to arrest the cells in mitosis by Mps1 overexpression. Cells were then transferred to phos-
phate-free CSM 1 2% galactose containing 32PO4, and treated as described in A. In B, cells were arrested by Mps1 overexpression at
238C, whereas in C cells were arrested at 358C. In all experiments, the Western blots shown below the autoradiographs illustrate that the
same amount of APC was immunoprecipitated in all strains (except for cdc26D strains, where no APC was precipitated).The Journal of Cell Biology, Volume 149, 2000 1382
teins abolishes in vivo phosphorylation of the APC (see
below).
Since Cdc28/Clb complexes are inactive in G1, the dif-
ferences in APC phosphorylation during different cell cy-
cle stages suggests this reaction depends on Cdc28/Clb
complexes. We tested this hypothesis directly by compar-
ing the phosphorylation of the APC in CDC28-VF, clb2D,
and cdc28-1N cells, three mutants that affect the mitotic
activity of Cdc28 (Piggott et al., 1982; Surana et al., 1991;
Grandin and Reed, 1993; Rudner et al., 2000). The cells
were arrested in metaphase at 258C (Fig. 2 B) or at 358C
(Fig. 2 C) by overexpressing Mps1 from the galactose
inducible GAL1 promoter, which activates the spindle
checkpoint. All three mutants reduce the phosphorylation
of the APC by a factor of 2–4 compared with wild-type.
Previous studies have suggested that in mammalian tis-
sue culture cells, the protein kinase Plk is primarily re-
sponsible for phosphorylating the APC (Kotani et al.,
1998). A mutant in CDC5, the yeast homologue of Plk,
cannot activate the Hct1-dependent APC (Charles et al.,
1998). To determine whether APC phosphorylation is de-
pendent on Cdc5, we examined APC phosphorylation in a
cdc5-1 mutant, arrested in metaphase by overexpressing
Mps1 at a semirestrictive temperature of 358C. We ob-
served a similar reduction in APC phosphorylation as in
CDC28-VF and cdc28-1N (Fig. 1 C), suggesting that Cdc5
contributes to APC phosphorylation in vivo.
To confirm the identities of the phosphorylated APC
subunits and to determine if the APC is phosphorylated by
Cdc28 in vivo, we mutated all the potential Cdc28 sites in
Cdc16, Cdc23, and Cdc27. Using the weakest possible con-
sensus phosphorylation site (serine or threonine, followed
by proline; S/TP) as our criterion, we mutated six sites in
Cdc16, one in Cdc23, and five in Cdc27. We refer to the re-
sulting genes as CDC16-6A CDC23-A and CDC27-5A. As
Fig. 3 A shows, most of the mutated sites fit only the mini-
mal S/TP motif and lack a nearby basic residue found
in many biochemically determined Cdk phosphorylation
sites (Brown et al., 1999).
We directly assessed the ability of the mutant subunits
to be phosphorylated in vivo and in vitro. In vivo, each ala-
nine-substituted subunit is resistant to phosphorylation
(Fig. 3 B). This result confirms our conclusion that Cdc16,
Cdc27, and Cdc23 are the three major phosphorylated
Figure 3. The APC is phosphorylated on potential Cdc28 phosphorylation sites. A, All serine/proline (SP) and threonine/proline (TP)
sites on Cdc16, Cdc23, and Cdc27 were mutated to alanine/proline (AP). B, Phosphorylation site mutants are resistant to phosphoryla-
tion in vivo. All strains contain pGAL-MPS1. Wild-type (KH153), CDC16-6A (ADR1975), CDC23-A-HA (ADR1973), CDC27-5A-
HA (ADR1974); and CDC16-6A CDC23-A CDC27-5A (ADR1979) and cdc26D (ADR2023) were grown in the presence of 32PO4 as
described in Fig. 1 B. C, Phosphorylation site mutants are resistant to phosphorylation in vitro. The APC was isolated and phosphory-
lated in vitro as described in Fig. 1 for: cdc26D (LH307), CDC23-A (ADR2030), wild-type (ADR376), CDC27-5A (ADR2031), CDC16-
6A (ADR2029), and CDC16-6A CDC23-A CDC27-5A (ADR2032).Rudner and Murray Cdc28 Phosphorylates the APC 1383
proteins in the APC (Fig. 2) and shows that among the
phosphorylation sites we mutated are the relevant in vivo
sites. In addition, the phosphorylation of the different sub-
units are largely independent of each other. For example,
the CDC23-A mutant eliminates the phosphorylation of
Cdc23, but not that of Cdc16 and Cdc27. In vitro, Cdc23-A
and Cdc27-5A are resistant to phosphorylation in vitro by
Cdc28 (Fig. 3 C). Cdc16-6A is still weakly phosphorylated,
though much less than the wild-type protein.
The APC Binds to Cks1
During the course of this work we discovered that the bud-
ding yeast APC, like the animal APC, can bind to Cks1-
coupled beads (Sudakin et al., 1997). This interaction is
thought to be critical for APC phosphorylation and re-
flects the ability of Cks1 to bring Cdc2/Cyclin B complexes
into proximity with the APC by interacting with both com-
plexes simultaneously (Patra and Dunphy, 1998; Shtein-
Figure 4. The APC associates with Cks1-coupled beads. A, The APC from CDC28-VF associates poorly with Cks-coupled beads. Wild-
type (ADR477) and CDC28-VF (ADR509) were grown overnight in YEP 1 2% glucose at 238C to log phase and arrested in mitosis
with nocodazole (10 mg/ml) for 3 h. Cells were harvested, lysed, and mixed with Cks1-coupled beads. Western blots of the material
bound to the Cks1-coupled beads show that the APC and Cdc28/Clb2 bind to the beads. B, Cdc27 phosphorylation can be seen by
Western blotting. Wild-type APC, isolated as described in A, was treated either with lambda phosphatase, lambda phosphatase and in-
hibitors, or inhibitors alone. C, APC association to Cks1-coupled beads changes through the cell cycle. Wild-type (ADR1389) and
CDC28-VF (ADR1252) were grown overnight at 308C in YPD to log phase, arrested in G1 with alpha factor (1 mg/ml), and at t 5 0 (al-
pha factor) the cells were released from the G1 arrest. At t 5 75, alpha factor (1.5 mg/ml) was added back to the cultures to rearrest the
cells in the next G1. A parallel sample was arrested in mitosis with nocodazole (10 mg/ml). Samples were taken at the indicated times
and processed for Western blots (top) or for Cks-coupled bead pulldowns (bottom). The arrow indicates that in wild-type cells when
Clb2 levels peak (t 5 75), Cdc16 and Cdc27 phosphorylation increases. The bracket indicates that in CDC28-VF cells when Clb2 levels
are peaking, Cdc27 phosphorylation decreases. D, An APC-containing Cdc27-5A does not bind to Cks1-coupled beads. The strains in
Fig. 3 B and CDC28-VF pGAL-MPS1 (KH181) were grown overnight in YEP 1 2% raffinose at 238C to log phase and then transferred
to YEP 1 2% galactose for 4 h to arrest the cells in mitosis by Mps1 overexpression. Samples were taken and processed for Western
blots (cell lysate), immunoprecipitation with anti-cdc26 antibodies, or Cks1-coupled bead pulldowns as described in Materials and
Methods. Equal amounts of lysates were used for the Cks1-coupled bead pulldown and the anti-Cdc26 immunoprecipitation, though a
longer exposure is shown for the Cks1-coupled bead pulldown. Clb2 is shown as a loading control. E, Mitotic Cdc28 activity is required
for APC phosphorylation. Wild-type (ADR376), CDC28-VF (ADR509), cdc28-1N (ADR483), cdc28-4 (ADR842), clb2D (ADR313),
and cks1-38 (ADR1767) were grown overnight in YEP 1 2% glucose at 238C to log phase and arrested in mitosis with nocodazole (10
mg/ml) for 3.5 h. Samples were taken at the indicated times and processed for Western blots. Clb3 is shown as a loading control.The Journal of Cell Biology, Volume 149, 2000 1384
berg and Hershko, 1999). Fig. 4 A shows that the APC
from mitotically arrested yeast cells binds to Cks1-coupled
beads. Comparing Western blots of the material recovered
from wild-type and CDC28-VF cells reveals that less APC
from CDC28-VF cells binds to Cks1-coupled beads. Re-
duced recovery of the APC does not reflect decreased
binding of Cdc28-VF to Cks1 beads, since equal amounts
of Cdc28-VF/Clb2 and Cdc28/Clb2 are recovered with the
beads.
Fig. 4 A also shows that Cdc27 runs as a doublet on
Western blots, with the upper band predominating in wild-
type and the lower band predominating in CDC28-VF.
The slower mobility form of Cdc27 is a phosphorylated
form because it can be converted to the faster one by
treating the Cks1-bound material with lambda phospha-
tase (Fig. 4 B). We are also able to detect phosphoryla-
tion-dependent mobility shifts in Cdc16 and Cdc23 (data
not shown). These phosphorylation-dependent shifts con-
firm our in vivo labeling data (Fig. 2) that show the APC is
phosphorylated in vivo.
To investigate the relationship between reduced Cks1
binding and reduced Cdc27 phosphorylation in CDC28-VF
cells, we followed both through the cell cycle. Fig. 4 C
shows that through most of the cell cycle Cdc27 is partially
phosphorylated, but as cells go through mitosis and Clb2
levels peak, Cdc27 and Cdc16 phosphorylation increases
(Fig. 4 C, arrow). The amount of phosphorylation on both
subunits increases further when nocodazole treatment ar-
rests cells in mitosis by activating the spindle checkpoint.
In CDC28-VF cells, as Clb2 levels increase, Cdc27 phos-
phorylation decreases before eventually returning to its
partially phosphorylated state (Fig. 4 C, bracket).
These changes in APC phosphorylation correlate with
its ability to bind Cks1-coupled beads (Fig. 4 C, bottom).
In wild-type, no APC binds Cks1-coupled beads in an al-
pha factor arrest, and its binding increases as levels of Clb2
rise. In CDC28-VF cells, little binding of the APC to Cks1-
coupled beads is seen at any stage of the cell cycle, even
though the peak levels of Clb2 are similar in wild-type and
CDC28-VF  cells. These differences suggest that mitotic
phosphorylation by Cdc28 is required for APC binding to
Cks1-coupled beads (Sudakin et al., 1997). Although the
difference in APC phosphorylation between wild-type and
CDC28-VF cells in a synchronous cell cycle is transient
and subtle, it is reproducible, and it correlates with a large
difference in the ability of the APC to bind Cks1-coupled
beads.
We next tested whether APC phosphorylation is re-
quired for the APC to bind Cks1-coupled beads. The
beads do not bind an APC containing Cdc27-5A (Fig. 4
D), but do bind an APC containing either Cdc16-6A and
Cdc23-A.  This result suggests that phosphorylation of
Cdc27 is critical for Cks1 binding to the APC.
We have shown that mutations that alter the mitotic ac-
tivity of Cdc28 have reduced APC phosphorylation (Fig. 2,
B and C). Our ability to detect APC phosphorylation on
Western blots allowed us to examine additional mutants
that affect Cdc28 activity. Mutants that reduce the mitotic
activity of Cdc28 (CDC28-VF, cdc28-1N, clb2D, and cks1-
38) are hypersensitive to checkpoint arrest caused by over-
expression of Mps1, whereas a mutant that primarily af-
fects G1 activity (cdc28-4) is not (Reed, 1980; Surana et
al., 1991; Tang and Reed, 1993; Rudner et al., 2000). To
test if this correlation extended to the phosphorylation
state of the APC, we arrested these strains in mitosis with
nocodazole and immunoblotted for Cdc27 and Cdc16.
This analysis correlates perfectly with our earlier findings:
cdc28-4 have normal levels of Cdc16 and Cdc27 phos-
phorylation, whereas clb2D, cdc28-1N, and cks1-38 all have
reduced levels and resemble CDC28-VF (Fig. 4 E).
APC Phosphorylation Site Mutants Affect Mitotic, but 
Not G1 Functions
We wanted to rule out the possibility that the phosphory-
lation site mutants had general effects on the activity of
the APC, as opposed to a specific effect on its mitotic,
Cdc20-dependent form. Since the Hct1-dependent APC is
maximally active when Cdc28 is inactive, loss of Cdc28-
dependent phosphorylations should not affect Hct1-
dependent APC activity in G1-arrested cells that lack ac-
tive Cdc28 (Zachariae et al., 1998; Jaspersen et al., 1999).
Therefore, we examined the activity of APC containing
the alanine-substituted subunits that had been isolated
from G1-arrested cells. APC activity was measured in an
in vitro ubiquitination assay that uses an iodinated frag-
ment of sea urchin cyclin B as a substrate and the APC
provided from anti-Cdc26 immunoprecipitates (Charles et
al., 1998). Fig. 5 shows that there is no difference in G1-
specific APC activity between wild-type cells and those
carrying alanine mutations in APC subunits (CDC16-6A,
CDC23-A, or CDC27-5A). Thus, the mutations in putative
Cdc28-dependent phosphorylation sites have not disrupted
the ability of these subunits to associate with other APC
components or produce normal levels of Hct1-dependent
Figure 5. The alanine-substituted APC has normal G1 APC ac-
tivity. The strains described in Fig. 3 C were grown overnight at
308C in YEP 1 2% glucose to log phase, and arrested in G1 with
alpha factor (1 mg/ml) for 3 h. The cells were harvested, lysed,
and the APC was immunoprecipitated with anti-Cdc26 antibod-
ies, and the in vitro ubiquitination activity of the immunoprecipi-
tates was measured. The substrate for the in vitro ubiquitination
is an iodinated NH2-terminal fragment of sea urchin Cyclin B
(CycB). Western blotting of the immunoprecipitates (bottom)
shows that equal amounts of Cdc16 and Cdc27 are present in the
APC isolated from each of the strains.Rudner and Murray Cdc28 Phosphorylates the APC 1385
APC activity. In addition, cells carrying alanine-substi-
tuted APC subunits show no obvious growth defects at
any temperature.
We asked if the alanine substitutions in the APC, like
CDC28-VF, have difficulty leaving mitosis (Rudner et al.,
2000). Wild-type and CDC16-6A CDC23-A CDC27-5A
cells were arrested in G1 by the mating pheromone alpha
factor and then released into the cell cycle. Once cells had
budded, alpha factor was readded to arrest cells that had
completed the cycle. CDC16-6A CDC23-A CDC27-5A cells
show a 20-min delay in sister chromatid separation (Fig. 6
A). Clb2 and Clb3 proteolysis are delayed by .40 min. This
defect is not due to slower mitotic entry, because wild-type
and CDC16-6A CDC23-A CDC27-5A cells initiate budding,
degrade Sic1, and form a short mitotic spindle at the same
time (Fig. 6 A and data not shown).
Mutating APC phosphorylation sites also causes an in-
creased sensitivity to spindle checkpoint arrest caused by
Mps1 overexpression (Hardwick et al., 1996; Rudner et al.,
2000). Serial dilutions of wild-type, CDC28-VF, mutants in
single APC subunits, double mutants, and the triple mu-
tant were spotted on plates where Mps1 is induced to high
levels (Fig. 6 B). Both CDC16-6A and CDC27-5A are sen-
sitive to Mps1 overexpression and combining the two mu-
Figure 6. The alanine-substi-
tuted APC delays in mitosis
and is sensitive to spindle
checkpoint-dependent arrest.
A, Wild-type (ADR2061)
and CDC16-6A CDC23-A
CDC27-5A  (ADR2064) were
grown overnight at 238C in
YPD to mid log phase, ar-
rested in G1 with alpha factor
(1  mg/ml), and at t 5 0 the
cells were released from the
G1 arrest. At t 5 80, alpha
factor (1.5 mg/ml) was added
back to the cultures to rear-
rest the cells in the next G1.
Top, Samples were taken at
the indicated times and pro-
cessed for Western blots.
Bottom left, Sister chromatid
separation was scored by
counting the number of fluo-
rescent spots (one or two) of
green fluorescent protein
(GFP)-lacI bound to 256 tan-
dem repeats of lacO inte-
grated at the LEU2 locus.
Bottom right, Spindles were
visualized by indirect immu-
nofluorescence of formalde-
hyde fixed cells probed with
an antialpha-tubulin anti-
body. B, All strains con-
tain  pGAL-MPS1. Wild-
type  (KH153),  CDC28-VF
(KH181),  CDC23-A  (ADR-
1973),  CDC27-5A  (ADR-
1974),  CDC16-6A  (ADR-
1975),  CDC23-A CDC27-5A
(ADR1976),  CDC16-6A
CDC23-A  (ADR1977),  CDC16-
6A CDC27-5A (ADR1978),
and  CDC16-6A CDC23-A
CDC27-5A  (ADR1979) were
grown to saturation for 2 d in
YEP 1 2% glucose at 308C,
diluted tenfold, and fourfold
serial dilutions were prepared
in a multiwell dish and spot-
ted onto YEP 1 2% glucose
(left) or YEP 1 2% galactose
(right). The plates were incu-
bated at 308C for 2 d.The Journal of Cell Biology, Volume 149, 2000 1386
tants creates a phenotype similar to that of CDC28-VF.
The CDC23-A mutation alone has little phenotype, but
exacerbates the effect of both the CDC16-6A and CDC27-
5A mutations. These data suggest that phosphorylation of
the APC subunits contribute to the ability to overcome the
spindle checkpoint and suggest that the alanine-substituted
APC, like CDC28-VF, may be defective in the Cdc20-
dependent APC.
To test Cdc20-dependent APC function more directly,
we examined the ability of these nonphosphorylatable
APC mutants to support Pds1 degradation in vivo. Pds1 is
normally unstable in anaphase with a half life of about ten
minutes (Jaspersen et al., 1998). We arrested wild-type
and nonphosphorylatable APC mutants in anaphase (us-
ing the cdc15-2 mutant), induced Pds1 expression from the
GAL1 promoter by adding galactose for one hour, and
then shut the promoter off by adding glucose and exam-
ined the rate of Pds1 degradation. Previously, we have
shown that in this anaphase arrest, CDC28-VF and clb2D
stabilize Pds1 (Rudner et al., 2000). We see a similar effect
when the CDC27-5A and CDC16-6A mutants are com-
bined with cdc15-2. The half life of Pds1 is increased to 30
min in anaphase-arrested CDC27-5A, and to .90 min in
CDC16-6A cells (Fig. 7 A).
We also have examined the association of Cdc20 with
the APC in the alanine-substituted mutants at the cdc15-2
block, a time when the Cdc20-dependent APC is active.
This association is impaired in CDC28-VF (Rudner et
Figure 7. The alanine-substi-
tuted APC is defective in
Cdc20-dependent APC func-
tion. A, Pds1 is stabilized in
anaphase in CDC16-6A and
CDC27-5A.  cdc15-2 GAL-
PDS1-HA  (ADR1968),
cdc15-2 CDC27-5A GAL-
PDS1-HA  (ADR1999), and
cdc15-2 CDC16-6A GAL-
PDS1-HA  (ADR2003) were
grown overnight at 238C in
YEP 1 2% raffinose to log
phase and shifted to 378C to
arrest the cells in anaphase
(raf). When . 85% of the
cells had reached anaphase
(after 4 h, as judged by nu-
clear division, which was
scored by 49,6-diamidino-
2-phenylindole [DAPI] stain-
ing), Pds1-HA expression
was induced for 1 h by the ad-
dition of 2% galactose, and at
t 5 0, its expression was ter-
minated by the addition of
2% glucose. Samples were
taken at the indicated times
and processed for Western
blots. Clb2 and Cdc27 are
shown as a loading controls.
B, Cdc20 binding to the APC
is impaired in CDC16-6A.
cdc15-2 CDC20-myc12
(ADR1790),  cdc15-2
CDC27-5A CDC20-myc12
(ADR1987),  cdc15-2
CDC20-myc12 CDC16-6A
(ADR1990), and cdc26D
CDC20-myc12 (ADR2036)
were grown overnight in
YEP  1  2% glucose at 238C to
log phase and transferred
into fresh YEP 1 2% glucose
at 378C. When .85% of the
cells were arrested in anaphase (4 h, as judged by nuclear division, which was scored by DAPI staining), the cells were harvested, lysed,
and the APC was immunoprecipitated with polyclonal anti-Cdc26 antibodies. The amount of Cdc20-myc12 bound to the APC was de-
termined by Western blotting the immunoprecipitates with the 9E10 antibody. Equal amounts of Cdc23 was precipitated with the anti-
Cdc26 antibodies (left) and equal amounts of cell lysate were used in the immunoprecipitation (right, cell lysate). cdc26D, which arrests
in metaphase, not anaphase, accumulates high levels of Cdc20 because Cdc20 stability is regulated by the APC (Prinz et al., 1998;
Shirayama et al., 1998).Rudner and Murray Cdc28 Phosphorylates the APC 1387
al., 2000). We arrested cdc15-2, cdc15-2 CDC16-6A, and
cdc15-2 CDC27-5A cells in anaphase, immunoprecipitated
the APC with anti-Cdc26 antibodies, and examined the
amount of associated Cdc20. The association of Cdc20 to
the APC is reduced in CDC27-5A cells and severely im-
paired in CDC16-6A cells (Fig. 7 B).
The Role of Cdc5 in APC Phosphorylation
Different groups debate whether Cdc2 (Cdk1) or Plk is
the major APC kinase in vivo (Lahav-Baratz et al., 1995;
Kotani et al., 1998; Patra and Dunphy, 1998; Shteinberg
and Hershko, 1999; Shteinberg et al., 1999). Since we find
that APC phosphorylation is reduced in a cdc5-1 mutant
(Fig. 2 C), we tested whether purified recombinant Cdc5
could phosphorylate the APC in vitro. Like Cdc28, Cdc5
phosphorylates Cdc16, Cdc27, and Apc9 (Fig. 8 A), but
unlike Cdc28, appears to not phosphorylate Cdc23. Cdc5
also phosphorylates proteins that have the molecular
weights of several other APC subunits (Apc1, -2, -4, and -5;
Zachariae et al., 1996). We have not confirmed the iden-
tity of these proteins because there is little evidence that
these proteins are major targets of phosphorylation in vivo
(Fig. 2). The ability of human Plk to activate the APC in
vitro depends on pretreatment with Cdc2/Cyclin B com-
plexes (Kotani et al., 1998), a result that has been inter-
preted to suggest that Cdc2 activates Plk’s kinase activity
against the APC. In our hands, however, Cdc5’s ability to
phosphorylate the APC does not increase when the kinase
is pretreated with purified Cdc28/Clb2/Cks1 complexes
(data not shown).
We next tested whether purified Cdc5 can phosphory-
late the alanine-substituted APC. The Cdk sites we mu-
tated on Cdc16, Cdc23, and Cdc27 are also potential sites
of phosphorylation by Cdc5. Substrates of the frog homo-
logue of Cdc5, Plx1, become epitopes for the MPM-2 anti-
body after phosphorylation by Plx1 (Kumagai and Dun-
phy, 1996) and MPM-2 recognizes phosphorylation at SP
or TP sites (Westendorf et al., 1994). In contrast to their
effect on phosphorylation by Cdc28, the APC phosphory-
lation site mutants had no effect on in vitro phosphoryla-
tion of the APC by recombinant Cdc5 (Fig. 8 B). This ob-
servation makes it likely that the reduced in vivo APC
phosphorylation seen in cdc5-1 cells is an indirect effect of
reduced Cdc5 activity, rather than a direct in vivo phos-
phorylation of these APC subunits by Cdc5.
Discussion
We have shown that the budding yeast APC subunits,
Cdc16, Cdc23, and Cdc27, are phosphorylated in vivo and
in vitro. Phosphorylation in vivo depends on Cdc28, and in
vitro it is catalyzed by pure Cdc28/Clb2/Cks1 complexes.
Mutating potential Cdc28 phosphorylation sites in Cdc16,
Cdc23, and Cdc27 abolishes their in vivo phosphorylation
and compromises the mitotic, but not the G1 functions of
the APC. We have also shown that Cdc5 affects APC
phosphorylation in vivo and can catalyze APC phosphory-
lation in vitro. Our analysis of APC phosphorylation site
mutants in vivo and in vitro, however, argues that in vivo
Cdc5 indirectly induces the phosphorylation of Cdc16,
Figure 8. Cdc5 phosphory-
lates the APC in vitro. A,
The APC was isolated from
the following strains as de-
scribed in Fig. 1: Wild-type
(ADR376),  APC9-HA3
(ADR2042),  CDC16-myc6
(K6180),  CDC23-HA
(SLJ378),  CDC27-MBP
(ADR1705), and cdc26D
(LH307). The immunopre-
cipitates were treated with
purified His6-HA-Cdc5 and
g[32P]ATP, washed to remove
phosphorylated His6-HA-
Cdc5, and run on a polyacryl-
amide gel that was subjected
to autoradiography (top) or
Western blotting (bottom).
The Western blot shows that
similar amounts of APC were
precipitated with the anti-
Cdc26 antibody from all
strains except APC9-HA3,
which does not fully comple-
ment a apc9D. B, The APC
was isolated from wild-type
(ADR376),  CDC16-6A
CDC23-A CDC27-5A
(ADR2032), and cdc26D
(LH307), and phosphory-
lated by purified His6-
HA-Cdc5.The Journal of Cell Biology, Volume 149, 2000 1388
Cdc23, or Cdc27, rather than directly modifying these sub-
units.
The APC Is Phosphorylated in Budding Yeast
Our results agree with studies on other organisms that
show mitosis-specific APC phosphorylation. Cdc16, Cdc23,
Cdc27, and Apc1 are phosphorylated in frogs; Apc1,
Cdc16, and Cdc27 are phosphorylated in mammalian tis-
sue culture cells; and Cdc16 (Cut 9) is phosphorylated in
fission yeast (Peters et al., 1996; Yamada et al., 1997; Patra
and Dunphy, 1998; Kotani et al., 1999). Although APC
phosphorylation has been shown to activate the Cdc20-
dependent APC in mammalian tissue culture and clam egg
extracts (Kotani et al., 1998; Shteinberg et al., 1999), and
Cks1 depletions prevent mitotic exit in frog extracts (Patra
and Dunphy, 1996), this is the first report to examine the
in vivo function of APC phosphorylation. Although phos-
phorylation of Cdc16, Cdc23, and Cdc27 is not essential
for viability in budding yeast, our studies suggest that it
stimulates Cdc20-dependent APC activity and Cdc20 bind-
ing to the APC in vivo.
Cdc27 remains partially phosphorylated in G1 cells (Fig.
4 C). The presence of slower migrating Cdc27 in G1 cells
could arise two ways: during the exit from mitosis, if
Cdc28-catalyzed phosphorylation declines after phospha-
tases have been inactivated; or in G1, by phosphorylation
catalyzed by another kinase. Because Cdc27-5A runs as a
single band on Western blots in G1 (Fig. 5), we favor the
possibility that G1 phosphorylation on Cdc27 remains
from the previous mitosis. This finding would suggest that
the phosphatase that removes phosphorylation from the
APC is only active in mitosis. PP2A has been proposed to
play such a role in clams and frogs (Lahav-Baratz et al.,
1995; Vorlaufer and Peters, 1998).
In one report, Plk has been identified as the major ki-
nase of the mammalian APC (Kotani et al., 1998), al-
though others have argued that this role is played by Cdc2
(Lahav-Baratz et al., 1995; Patra and Dunphy, 1998;
Shteinberg and Hershko, 1999; Shteinberg et al., 1999).
We asked if its budding yeast homologue, Cdc5, plays a
similar role. In vivo, APC phosphorylation is reduced in
the cdc5-1 mutant and purified Cdc5 phosphorylates the
APC in vitro (Figs. 2 C and 8 A). Three observations argue
that in living cells Cdc5 does not directly phosphorylate the
APC subunits we have studied: phosphorylation site muta-
tions that completely block phosphorylation of Cdc16,
Cdc23, and Cdc27 in vivo, do not block in vitro phosphory-
lation of these subunits by Cdc5 (Fig. 8 B); purified Cdc28/
Clb2/Cks1, that lacks detectable Cdc5, efficiently phos-
phorylates immunoprecipitated APC (Fig. 1); and the same
mutations that block Cdc28-catalyzed phosphorylation in
vitro also block in vivo APC phosphorylation (Fig. 3).
If Cdc5 does not phosphorylate Cdc16, Cdc23, and
Cdc27 directly, how does it regulate the phosphorylation
of these subunits? Cdc5 may be responsible for phos-
phorylating other APC subunits (Apc1, -2, -4, and -5 are
potential substrates; Fig. 8) in vivo, and the phosphoryla-
tion of these subunits may affect the phosphorylation of
the Cdc28 targets Cdc16, Cdc23, and Cdc27. Alternatively,
Cdc5 may modulate Cdc28/Clb/Cks1 activity or localiza-
tion.
Phosphorylation Stimulates Cdc20-dependent
APC Activity
We have shown that phosphorylation site mutants in the
APC reduce activation of the Cdc20-dependent APC. The
half-life of Pds1 is increased in CDC27-5A and CDC16-6A
cells, and this defect in Cdc20 function could be explained
by the observed inability of Cdc20 to bind an APC con-
taining Cdc16-6A. This data supports genetic experiments
showing that reduced mitotic Cdc28 activity compromises
the Cdc20-dependent APC (Rudner et al., 2000).
If Cdc20 binding and activity depend on a phosphory-
lated APC, why is the triple mutant CDC16-6A CDC23-A
CDC27-5A viable? Even in the triple mutant there is some
residual Cdc20 binding to the APC (data not shown),
which is presumably sufficient to drive the metaphase to
anaphase transition. The residual binding of Cdc20 to the
APC could depend on the phosphorylation of the other
subunits. In support of this idea, we see weak phosphory-
lation of proteins we believe to be Apc1, -4, -5, and -9 in
some in vivo labelings (data not shown), and a protein we
believe to be Apc9 is phosphorylated in vitro by Cdc28/
Clb2/Cks1 complexes (data not shown and Fig. 1; Zach-
ariae et al., 1996). In addition, cdc28-1N, a mutation in
Cdc28 that cannot bind Cks1 (Kaiser et al., 1999; and data
not shown) and cks1-38, have reduced APC phosphoryla-
tion (Figs. 1 C and 4 E). These two mutants are tempera-
ture-sensitive for growth and arrest in mitosis (Piggott et
al., 1982; Tang and Reed, 1993), suggesting that APC
phosphorylation may be essential. Alternatively, it has
been proposed that the primary defect in cdc28-1N and
cks1-38 is in proteasome function (Kaiser et al., 1999),
though proteasome activity was examined in G1, not in
mitosis, leaving the relevance of this finding to the exit
from mitosis uncertain.
Our data suggests that activation of the APC by phos-
phorylation opposes its inhibition by the spindle check-
point. Although CDC16-6A CDC23-A CDC27-5A is via-
ble, its delay in mitosis (Fig. 6 A) becomes lethal when the
spindle checkpoint is activated (Fig. 6 B). Both APC phos-
phorylation and the spindle checkpoint affect the ability of
Cdc20 to activate the APC, but have no effects on the G1,
Hct1-dependent activity of the APC.
Regulation of APC Phosphorylation
Phosphorylation of the APC in frogs and clams in vitro de-
pends on homologues of the small Cdk binding protein,
Cks1, and in clams, Cks1 stimulates Cdc20-dependent
APC activity (Patra and Dunphy, 1998; Shteinberg and
Hershko, 1999; Shteinberg et al., 1999). In budding yeast,
the role of Cks1 remains uncertain. Although we add puri-
fied Cks1 to our in vitro kinase reactions, Cks1 is not
required for APC phosphorylation in vitro (Fig. 1 and
data not shown). However, APC phosphorylation in vivo
clearly depends on Cks1 (Fig. 4 E) and phosphorylation of
Cdc27 is required for APC binding to Cks1-coupled beads
(Fig. 4 D). We do not think that the binding of the APC to
Cks1-coupled beads correlates with the ability of Cdc28 to
phosphorylate the APC in vivo: although an APC contain-
ing Cdc27-5A does not bind to Cks1-coupled beads, Cdc16
and Cdc23 are fully phosphorylated in a CDC27-5A mu-
tant. Despite this in vivo finding, we do see reduced inRudner and Murray Cdc28 Phosphorylates the APC 1389
vitro phosphorylation of Cdc16 and Cdc23 in an APC con-
taining Cdc27-5A (Fig. 3 C).
Mutants that affect the mitotic form of Cdc28 have re-
duced levels of phosphorylation of the APC, whereas
cdc28-4 cells, which are defective in the G1 form of Cdc28
(Reed, 1980), show normal phosphorylation of Cdc27 and
Cdc16. We were surprised to discover that APC phosphor-
ylation in cdc28-4 appears to be normal (Fig. 4 E), because
this mutant has z20% the amount of Cdc28 protein as
wild-type cells at the permissive temperature of 238C, and
very little detectable Cdc28-associated kinase activity
when immunoprecipitated from cell lysates (Surana et al.,
1991; and data not shown). A possible explanation of the
absence of mitotic defects in cdc28-4 cells is that the spe-
cific activity of each Cdc28-4 molecule is equal to that of
wild-type Cdc28, although the total number of active ki-
nases is drastically reduced. The specific activity of indi-
vidual Cdc28 molecules may be critical for APC phosphor-
ylation because one Cdc28/Clb2/Cks1 complex may bind
persistently to the APC. Once bound to the APC, this sin-
gle complex might be responsible for multiple phosphory-
lations. If the steady state phosphorylation of the APC is
determined by the balance between phosphorylation by
Cdc28 and dephosphorylation by protein phosphatases,
and Cdc28 remains bound to the APC, a drop in specific
activity of Cdc28 would reduce the phosphorylation and
activity of the APC.
How do cells escape from mitosis? If activating Cdc28/
Clb/Cks1 complexes activates the Cdc20-dependent APC,
which in turn triggers chromosome segregation, how do
cells ensure that the lag between activating Cdc28 and ac-
tivating the Cdc20-dependent APC is long enough to as-
semble a spindle and align chromosomes on it? Although
one answer is that the spindle checkpoint inhibits Cdc20 in
cells with misaligned chromosomes (Hwang et al., 1998;
Kim et al., 1998), this explanation is not enough. Inactivat-
ing the spindle checkpoint does not kill yeast cells, imply-
ing other mechanisms exist to block premature activation
of the Cdc20-dependent APC. Another possible mecha-
nism is regulating the abundance of Cdc20. High levels of
CDC20 transcripts are restricted to mitotic cells and APC-
dependent proteolysis restricts the abundance of Cdc20
(Weinstein, 1997; Kramer et al., 1998; Prinz et al., 1998;
Shirayama et al., 1998). None of these forms of regulation
exist in early frog embryos, where Cdc20 (Fizzy) levels are
constant through the cell cycle and spindle depolymeriza-
tion does not induce mitotic arrest (Minshull et al., 1994;
Lorca et al., 1998). In addition, overexpressing Cdc20 in
budding yeast raises the level of Cdc20 mRNA and pro-
tein, but does not advance the exit from mitosis, suggest-
ing that other mechanisms must exist to regulate Cdc20-
dependent APC activity (Prinz et al., 1998). Regulating
the rate of Cdc28-catalyzed APC phosphorylation pro-
vides an additional mechanism. If this phosphorylation
were slow relative to spindle assembly, most cells would
manage to align their chromosomes on the spindle before
activating the Cdc20-dependent APC, which in turn in-
duces Pds1 destruction and anaphase.
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